Related content

The AGEs-RAGE axis and nonalcoholic steatohepatitis: the evidence mounts

By Yilmaz Yusuf  

Journal of Gastroenterology, Vol. 45, Iss. 7, 2010-07 ,pp. : 782-783

Springer Publishing Company

Access to resources Recommend Favorite

Reply to the letter by I. Tasci regarding ‘Clinical usefulness of AGEs as a biomarker for the attenuation of NASH’

By Hyogo Hideyuki  

Journal of Gastroenterology, Vol. 45, Iss. 7, 2010-07 ,pp. : 781-781

Springer Publishing Company

Access to resources Recommend Favorite

Hepatocellular carcinoma with nonalcoholic steatohepatitis

By Mori Sayaka   Yamasaki Takahiro   Sakaida Isao   Takami Taro   Sakaguchi Eiki   Kimura Teruaki   Kurokawa Fumie   Maeyama Shiro   Okita Kiwamu  

Journal of Gastroenterology, Vol. 39, Iss. 4, 2004-04 ,pp. : 391-396

Springer Publishing Company

Access to resources Recommend Favorite

Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH

By Kimura Yuki   Hyogo Hideyuki   Yamagishi Sho-ichi   Takeuchi Masayoshi   Ishitobi Tomokazu   Nabeshima Yoshitaka   Arihiro Koji   Chayama Kazuaki  

Journal of Gastroenterology, Vol. 45, Iss. 7, 2010-07 ,pp. : 750-757

Springer Publishing Company

Access to resources Recommend Favorite

Nonalcoholic steatohepatitis associated with psoriasis vulgaris

By Matsumoto Teruo   Suzuki Norihisa   Watanabe Hiroshi   Irie Makoto   Iwata Kaoru   Anan Akira   Nakane Hidetoshi   Yoshikane Makoto   Nishizawa Shinya   Sohda Tetsuro   Sakisaka Shotaro  

Journal of Gastroenterology, Vol. 39, Iss. 11, 2004-11 ,pp. : 1102-1105

Springer Publishing Company

Access to resources Recommend Favorite